A pathophysiology-based approach to the management of early priapism

Asian Journal of Andrology

Volumn 15, Issue 1, 2013, Pages 20-26

  Kovac, Jason R ^a   Mak, Siu K ^b   Garcia, Maurice M ^c   Lue, Tom F ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

algorithm; ischemic; management; priapism; T shunt; tunneling

Indexed keywords

ACETYLSALICYLIC ACID; BACLOFEN; DIGOXIN; ESTRADIOL; FINASTERIDE; GABAPENTIN; HYDROXYUREA; PHENYLEPHRINE; SILDENAFIL; TADALAFIL;

ASPIRATION; HUMAN; INTRACORPORAL ASPIRATION; ISCHEMIC PRIAPISM; NON ISCHEMIC PRIAPISM; PATHOPHYSIOLOGY; PRIAPISM; REVIEW; SHUNTING; SMOOTH MUSCLE CONTRACTION; STUTTERING PRIAPISM; SURGICAL TECHNIQUE; T SHUNT; TUNNELING;

ALGORITHMS; DISEASE MANAGEMENT; HUMANS; ISCHEMIA; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PENILE ERECTION; PENIS; PRIAPISM;

EID: 84872198792     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2012.83     Document Type: Review

References (73)

1. Tripe J. Case of continued priapism. Lancet 1845; 2: 8.
2. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP et al. American Urological Association guideline on the management of priapism. J Urol 2003; 170: 1318-24. (Pubitemid 37108148)
3. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A et al. Priapism: Pathogenesis, epidemiology, and management. J Sex Med 2010; 7: 476-500.
4. Brant WO, Garcia MM, Bella AJ, Chi T, Lue TF. T-Shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol 2009; 181: 1699-705.
5. Huang YC, Harraz AM, Shindel AW, Lue TF. Evaluation and management of priapism: 2009 update. Nat Rev Urol 2009; 6: 262-71.
6. Hinman F. Report of case in a clinical study of the literature with reference to its pathogenesis and surgical treatments. Ann Surg 1914; 60: 689-716.
7. Lin G, Xin ZC, Lue TF, Lin CS. Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 2003; 170: S15-8; discussion S9. (Pubitemid 36859545)
8. Bivalacqua TJ, Burnett AL. Priapism: New concepts in the pathophysiology and new treatment strategies. Curr Urol Rep 2006; 7: 497-502. (Pubitemid 44663244)
9. Hauri D, Spycher M, Bruhlmann W. Erection and priapism: A new physiopathological concept. Urol Int 1983; 38: 138-45. (Pubitemid 13094034)
10. Garcia MM, Porten S, Lue TF. Commentary on refractory ischemic priapism. Transl Androl Urol 2011; 1: 61-5.
11. Zheng DC, Yao HJ, Zhang K, Xu MX, Chen Q et al. Unsatisfactory outcomes of prolonged ischemic priapism without early surgical shunts: Our clinical experience and a review of the literature. Asian J Androl. 2012 Aug 27. doi: 0.1038/aja.2012.63. [Epub ahead of print
12. Burt FB, Schirmer HK, Scott WW. A new concePTin the management of priapism. J Urol 1960; 83: 60-1.
13. Mwamukonda KB, Chi T, Shindel AW, Lue TF. Androgen blockade for the treatment of high-flow priapism. J Sex Med 2010; 7: 2532-7.
14. Hatzichristou D, Salpiggidis G, Hatzimouratidis K, Apostolidis A, Tzortzis V et al. Management strategy for arterial priapism: Therapeutic dilemmas. J Urol 2002; 168: 2074-7.
15. Gratzke C, Angulo J, Chitaley K, Dai Y, Kim NN et al. Anatomy, physiology and pathophysiology of erectile dysfunction. J Sex Med 2010; 7: 445-75.
16. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231-6. (Pubitemid 24352442)
17. Kovac JR, Preiksaitis HG, Sims SM. Functional and molecular analysis of L-Type calcium channels in human esophagus and lower esophageal sphincter smooth muscle. Am J Physiol Gastrointest Liver Physiol 2005; 289: G998-1006. (Pubitemid 41740603)
18. Kovac JR, Chrones T, Sims SM. Temporal and spatial dynamics underlying capacitative calcium entry in human colonic smooth muscle. Am J Physiol Gastrointest Liver Physiol 2008; 294: G88-98.
19. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001; 22: 32-9. (Pubitemid 32126284)
20. Jaffe AB, Hall A. Rho GTPases: Biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21: 247-69.
21. Sims SM, Chrones T, Preiksaitis HG. Calcium sensitization in human esophageal muscle: Role for RhoA kinase in maintenance of lower esophageal sphincter tone. J Pharmacol Exp Ther 2008; 327: 178-86.
22. Somlyo AP, Somlyo AV. Ca21 sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003; 83: 1325-58. (Pubitemid 37222274)
23. Wang H, Eto M, Steers WD, Somlyo AP, Somlyo AV. RhoA-mediated Ca21 sensitization in erectile function. J Biol Chem 2002; 277: 30614-21. (Pubitemid 34970756)
24. Burnett AL. Nitric oxide in the penis - Science and therapeutic implications from erectile dysfunction to priapism. J Sex Med 2006; 3: 578-82.
25. Burnett AL. Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health. J Androl 2008; 29: 3-14.
26. Lin CS. Phosphodiesterase type 5 regulation in the penile corpora cavernosa. J Sex Med 2009; 6 (SUPPL3): 203-9.
27. Dai Y, Zhang Y, Phatarpekar P, Mi T, Zhang H et al. Adenosine signaling, priapism and novel therapies. J Sex Med 2009; 6 (SUPPL3): 292-301.
28. Eland IA, van der Lei J, Stricker BH, Sturkenboom MJ. Incidence of priapism in the general population. Urology 2001; 57: 970-2. (Pubitemid 32405323)
29. Klein EA, Montague DK, Steiger E. Priapism associated with the use of intravenous fat emulsion: Case reports and postulated pathogenesis. J Urol 1985; 133: 857-9. (Pubitemid 15036427)
30. Hebuterne X, Frere AM, Bayle J, Rampal P. Priapism in a patient treated with total parenteral nutrition. JPEN J Parenter Enteral Nutr 1992; 16: 171-4.
31. Saenz de Tejada I, Kim NN, Daley JT, Royai R, Hypolite J et al. Acidosis impairs rabbit trabecular smooth muscle contractility. J Urol 1997; 157: 722-6. (Pubitemid 27026881)
32. Broderick GA, Gordon D, Hypolite J, Levin RM. Anoxia and corporal smooth muscle dysfunction: A model for ischemic priapism. J Urol 1994; 151: 259-62. (Pubitemid 24046985)
33. Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol 1986; 135: 142-7.
34. Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL. Phosphodiesterase-dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci USA 2005; 102: 1661-6. (Pubitemid 40209224)
35. Bivalacqua TJ, Ross AE, Strong TD, Gebska MA, Musicki B et al. Attenuated RhoA/ Rho-kinase signaling in penis of transgenic sickle cell mice. Urology 2010; 76: 510 e7-12.
36. Secil M, Arslan D, Goktay AY, Esen AA, Dicle O et al. The prediction of papaverine induced priapism by color Doppler sonography. J Urol 2001; 165: 416-8. (Pubitemid 32060426)
37. Pryor J, Akkus E, Alter G, Jordan G, Lebret T et al. Priapism. J Sex Med 2004; 1: 116-20. (Pubitemid 40424675)
38. Wear JB Jr, Crummy AB, Munson BO. A new approach to the treatment of priapism. J Urol 1977; 117: 252-4. (Pubitemid 8047863)
39. Kulmala RV, Tamella TL. Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs. Int J Impot Res 1995; 7: 131-6.
40. Broderick GA, Harkaway R. Pharmacologic erection: Time-Dependent changes in the corporal environment. Int J Impot Res 1994; 6: 9-16.
41. Pryor JP, Hehir M. The management of priapism. Br J Urol 1982; 54: 751-4. (Pubitemid 13179617)
42. Pryor JP. Priapism. Practitioner 1982; 226: 1873-9.
43. Broderick GA. Priapism. In: Kavoussi L, Novick A, Partin A, Peters C, editors. Campbell-Walsh Urology. 10th edn. Philadephia, PA: Elsevier Saunders; 2012. p749-69.
44. Garcia MM, Shindel AW, Lue TF. T-Shunt with or without tunnelling for prolonged ischaemic priapism. BJU Int 2008; 102: 1754-64.
45. Burnett AL, Pierorazio PM. Corporal 'snake' maneuver: Corporoglanular shunt surgical modification for ischemic priapism. J Sex Med 2009; 6: 1171-6.
46. Rees RW, Kalsi J, Minhas S, Peters J, Kell P et al. The management of low-flow priapism with the immediate insertion of a penile prosthesis. BJU Int 2002; 90: 893-7. (Pubitemid 36693625)
47. Ralph DJ, Garaffa G, Muneer A, Freeman A, Rees R et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur Urol 2009; 56: 1033-8.
48. Adeyoju AB, Olujohungbe AB, Morris J, Yardumian A, Bareford D et al. Priapism in sickle-cell disease; incidence, risk factors and complications - An international multicentre study. BJU Int 2002; 90: 898-902. (Pubitemid 36693626)
49. Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 1999; 21: 518-22. (Pubitemid 30305987)
50. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Long-Term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology 2006; 67: 1043-8. (Pubitemid 43956437)
51. Bivalacqua TJ, Champion HC, Mason W, Burnett AL. Long-Term phosphodiesterase type 5 inhibitor therapy reduces priapic activity in transgenic sickle cell mice. J Urol 2006; 175: 387.
52. Bialecki E, Bridges K. Sildenafil relieves priapism in patients with sickle cell disease. Am J Med 2002; 113: 252. (Pubitemid 35245640)
53. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med 2006; 3: 1077-84. (Pubitemid 44644720)
54. Beltran A, Concepcion F, Manzanares D, Garrido G, Glaria L et al. Heparin and low molecular weight heparin decrease nitric oxide production by human polymorphonuclear cells. Arch Med Res 1999; 30: 116-9. (Pubitemid 29255684)
55. Kato G. Priapism in sickle cell disease: A hematologist's perspective. J Sex Med 2012; 9: 70-8.
56. Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL. New insights into the pathophysiology of sickle cell disease-Associated priapism. J Sex Med 2012; 9: 79-87.
57. Jeong WI, Do SH, Yun HS, Song BJ, Kim SJ et al. Hypoxia potentiates transforming growth factor-Beta expression of hepatocyte during the cirrhotic condition in rat liver. Liver Int 2004; 24: 658-68.
58. Ul-Hasan M, El-Sakka AI, Lee C, Yen TS, Dahiya R et al. Expression of TGF-Beta-1 mRNA and ultrastructural alterations in pharmacologically induced prolonged penile erection in a canine model. J Urol 1998; 160: 2263-6.
59. Border WA, Noble NA. Fibrosis linked to TGF-Beta in yet another disease. J Clin Invest 1995; 96: 655-6.
60. Nolan VG, Wyszynski DF, Farrer LA, Steinberg MH. Hemolysis-Associated priapism in sickle cell disease. Blood 2005; 106: 3264-7. (Pubitemid 41565928)
61. Mi T, Abbasi S, Zhang H, Uray K, Chunn JL et al. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest 2008; 118: 1491-501. (Pubitemid 351500442)
62. Tong Y, Tiplitsky SI, Tar M, Melman A, Davies KP. Transcription of G-Protein coupled receptors in corporeal smooth muscle is regulated by the endogenous neutral endopeptidase inhibitor sialorphin. J Urol 2008; 180: 760-6.
63. Davies KP. The role of opiorphins (endogenous neutral endopeptidase inhibitors) in urogenital smooth muscle biology. J Sex Med 2009; 6 (SUPPL3): 286-91.
64. Tong Y, Tar M, Melman A, Davies K. The opiorphin gene (ProL1) and its homologues function in erectile physiology. BJU Int 2008; 102: 736-40.
65. Kanika ND, Tar M, Tong Y, Kuppam DS, Melman A et al. The mechanism of opiorphininduced experimental priapism in rats involves activation of the polyamine synthetic pathway. Am J Physiol Cell Physiol 2009; 297: C916-27.
66. Steinberg J, Eyre R. Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue. J Urol 1995; 153: 152.
67. van Driel M, Joosten E, Mensink H. Intrasorporeal self-injection with epinephrine as treatment for idiopathic recurrent priapism. Eur Urol 1990; 17: 95.
68. Rourke KF, Fischler AH, Jordan GH. Treatment of recurrent idiopathic priapism with oral baclofen. J Urol 2002; 168: 2552; discussion-3.
69. Rachid-Filho D, Cavalcanti A, Favorito L, Costa W, Sampaio F. Treatment of recurrent priapism in sickle cell anemia with finasteride: A new approach. Urology 2009; 74: 1054-7.
70. Wu A, Lue TF. Commentary on high flow, non-ischemic, priapism. Transl Androl Urol 2012; 1: 109-12.
71. Brock G, Breza J, Lue TF, Tanagho EA. High flow priapism: A spectrum of disease. J Urol 1993; 150: 968-71. (Pubitemid 23241314)
72. Hakim LS, Kulaksizoglu H, Mulligan R, Greenfield A, Goldstein I. Evolving concepts in the diagnosis and treatment of arterial high flow priapism. J Urol 1996; 155: 541-8. (Pubitemid 26023541)
73. Kumar R, Shrivastava DN, Seth A. Spontaneous resolution of delayed onset, posttraumatic high-flow priapism. J Postgrad Med 2006; 52: 298-9. (Pubitemid 44862773)